Bench to bedside: the challenges

We have asked three clinician-researchers to outline some of the challenges of getting new therapies from the lab to the person with Parkinson’s. The drug development process is lengthy. “The process of going through all the pharmacological studies in basic science and in different types of animals takes a long time,” says Dr. Michel Panisset, … Read more

Participating in clinical trials

First Person – Else Manz At 58, I was proud of my healthy diet, active lifestyle and my near-empty medicine chest which held only calcium and vitamin D. Life was good. However, I had also spent a full year quietly reviewing many sources, including my nursing texts, to determine the probable cause of the resting … Read more

Benefits and risks of participating in a clinical trial

Benefits Clinical trials that are well-designed and well-executed offer excellent opportunities for eligible participants to: Play an active role in their own health care. Obtain referrals to a study site. Engage care partners as companions in care. Gain access to new research treatments before they are widely available. Obtain expert medical, sometimes multidisciplinary, care at … Read more

Ethical Issues in Clinical Trial Participation

Ann Heesters Director of Ethics and Spiritual Care Toronto Rehabilitation Institute Marleen Van Laethem Research Ethicist Toronto Rehabilitation Institute What is a major misunderstanding people have about clinical trials? A clinical trial is a research study testing a new potential treatment. “Therapeutic misconception” is the name ethicists give to the misconception or confusion people have … Read more

New directions in Parkinson’s treatments

Slowing down or modifying disease progression Current drugs for Parkinson’s treat the symptoms but do not stop the progression. One of the biggest investments in Parkinson’s research is in trying to find a drug that will slow down or modify the disease progression. Azilect® The drug rasagiline (Azilect®) was studied recently to determine if it … Read more

National Study of Neurological Conditions Gets Underway

It is with great excitement that we announce that the first-ever national study of neurological conditions in Canada is now underway. Parkinson Society Canada (PSC) has played a lead role in advocating for this study which aims to improve our understanding of the experience and impact of neurological conditions, like Parkinson’s, so that policy makers … Read more

New in Parkinson’s research

Chewing gum holds promise for people with Parkinson’s Family history of melanoma and Parkinson disease risk Toronto scientists awarded $150,000 by Parkinson Society Canada to improve treatment for people with Parkinson’s Ottawa scientists awarded $205,000 by Parkinson Society Canada with funds raised in SuperWalk comments